Subject category:
Finance, Accounting and Control
Published by:
Ivey Publishing
Version: 2002-04-18
Length: 14 pages
Data source: Field research
Share a link:
https://casecent.re/p/14733
Write a review
|
No reviews for this item
This product has not been used yet
Abstract
Hemosol is a small biotech company that is under pressure to meet its research and development targets. The company is anticipating the completion of the second phase of testing of one of its products within the next year. Before the company can move on to the next phase of testing, Hemosol must obtain more capital. The company will need to rely on the investment community for funding, however, they have been struggling with developing relationships with investors. Hemosol''s president has approached the executive vice-president of the Equicom Group Inc, an investor relations firms, for assistance in putting a strategic plan together to improve the company''s performance and reputation.
About
Abstract
Hemosol is a small biotech company that is under pressure to meet its research and development targets. The company is anticipating the completion of the second phase of testing of one of its products within the next year. Before the company can move on to the next phase of testing, Hemosol must obtain more capital. The company will need to rely on the investment community for funding, however, they have been struggling with developing relationships with investors. Hemosol''s president has approached the executive vice-president of the Equicom Group Inc, an investor relations firms, for assistance in putting a strategic plan together to improve the company''s performance and reputation.